Table 3.

Most Common Adverse Events Reported in Select^* GetGoal Trials¹⁷–²⁷

Adverse Event	Lixisenatide	Placebo	Comparable GLP-1 RA
Nausea	25%	10%	35%
Vomiting	10%	2%	13%
Headache	8%	11%	NA
Diarrhea	10%	8%	13%
Dizziness	5%	2%	NA
Symptomatic hypoglycemia	9%	8%	8%

^*Includes GetGoal-Mono, GetGoal-M, GetGoal-F1, GetGoal-S, GetGoal-P, GetGoal-X, GetGoal-L, and GetGoal-Duo1.

GLP-1 RA = glucagon-like peptide-1 receptor agonist; NA = not applicable.